These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 36114272)

  • 1. A high-throughput screening campaign against PFKFB3 identified potential inhibitors with novel scaffolds.
    Li J; Zhou Y; Eelen G; Zhou QT; Feng WB; Labroska V; Ma FF; Lu HP; Dewerchin M; Carmeliet P; Wang MW; Yang DH
    Acta Pharmacol Sin; 2023 Mar; 44(3):680-692. PubMed ID: 36114272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Small molecule 3PO inhibits glycolysis but does not bind to 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 (PFKFB3).
    Emini Veseli B; Perrotta P; Van Wielendaele P; Lambeir AM; Abdali A; Bellosta S; Monaco G; Bultynck G; Martinet W; De Meyer GRY
    FEBS Lett; 2020 Sep; 594(18):3067-3075. PubMed ID: 32620030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blockage of glycolysis by targeting PFKFB3 suppresses the development of infantile hemangioma.
    Yang K; Qiu T; Zhou J; Gong X; Zhang X; Lan Y; Zhang Z; Ji Y
    J Transl Med; 2023 Feb; 21(1):85. PubMed ID: 36740704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro angiogenesis inhibition with selective compounds targeting the key glycolytic enzyme PFKFB3.
    Abdali A; Baci D; Damiani I; Belloni F; De Dominicis C; Gelmi ML; Corsini A; Bellosta S
    Pharmacol Res; 2021 Jun; 168():105592. PubMed ID: 33813027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphotoxin-α promotes tumor angiogenesis in HNSCC by modulating glycolysis in a PFKFB3-dependent manner.
    Yang JG; Wang WM; Xia HF; Yu ZL; Li HM; Ren JG; Chen G; Wang BK; Jia J; Zhang W; Zhao YF
    Int J Cancer; 2019 Sep; 145(5):1358-1370. PubMed ID: 30785217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 activity in response to EGFR signaling contributes to non-small cell lung cancer cell survival.
    Lypova N; Telang S; Chesney J; Imbert-Fernandez Y
    J Biol Chem; 2019 Jul; 294(27):10530-10543. PubMed ID: 31126985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of 6-phosphofructo-2-kinase (PFKFB3) suppresses glucose metabolism and the growth of HER2+ breast cancer.
    O'Neal J; Clem A; Reynolds L; Dougherty S; Imbert-Fernandez Y; Telang S; Chesney J; Clem BF
    Breast Cancer Res Treat; 2016 Nov; 160(1):29-40. PubMed ID: 27613609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. YAP promotes ocular neovascularization by modifying PFKFB3-driven endothelial glycolysis.
    Feng Y; Zou R; Zhang X; Shen M; Chen X; Wang J; Niu W; Yuan Y; Yuan F
    Angiogenesis; 2021 Aug; 24(3):489-504. PubMed ID: 33400016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphorylation of the 6-phosphofructo-2-kinase/fructose 2,6-bisphosphatase/PFKFB3 family of glycolytic regulators in human cancer.
    Bando H; Atsumi T; Nishio T; Niwa H; Mishima S; Shimizu C; Yoshioka N; Bucala R; Koike T
    Clin Cancer Res; 2005 Aug; 11(16):5784-92. PubMed ID: 16115917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small-molecule inhibition of 6-phosphofructo-2-kinase activity suppresses glycolytic flux and tumor growth.
    Clem B; Telang S; Clem A; Yalcin A; Meier J; Simmons A; Rasku MA; Arumugam S; Dean WL; Eaton J; Lane A; Trent JO; Chesney J
    Mol Cancer Ther; 2008 Jan; 7(1):110-20. PubMed ID: 18202014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting the Warburg Effect in cancer; relationships for 2-arylpyridazinones as inhibitors of the key glycolytic enzyme 6-phosphofructo-2-kinase/2,6-bisphosphatase 3 (PFKFB3).
    Brooke DG; van Dam EM; Watts CK; Khoury A; Dziadek MA; Brooks H; Graham LJ; Flanagan JU; Denny WA
    Bioorg Med Chem; 2014 Feb; 22(3):1029-39. PubMed ID: 24398380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PFKFB3 gene deletion in endothelial cells inhibits intraplaque angiogenesis and lesion formation in a murine model of venous bypass grafting.
    Perrotta P; de Vries MR; Peeters B; Guns PJ; De Meyer GRY; Quax PHA; Martinet W
    Angiogenesis; 2022 Feb; 25(1):129-143. PubMed ID: 34432198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 6-Phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 and 4: A pair of valves for fine-tuning of glucose metabolism in human cancer.
    Yi M; Ban Y; Tan Y; Xiong W; Li G; Xiang B
    Mol Metab; 2019 Feb; 20():1-13. PubMed ID: 30553771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The PFKFB3 Inhibitor AZ67 Inhibits Angiogenesis Independently of Glycolysis Inhibition.
    Emini Veseli B; Van Wielendaele P; Delibegovic M; Martinet W; De Meyer GRY
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34073144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Partial and transient reduction of glycolysis by PFKFB3 blockade reduces pathological angiogenesis.
    Schoors S; De Bock K; Cantelmo AR; Georgiadou M; Ghesquière B; Cauwenberghs S; Kuchnio A; Wong BW; Quaegebeur A; Goveia J; Bifari F; Wang X; Blanco R; Tembuyser B; Cornelissen I; Bouché A; Vinckier S; Diaz-Moralli S; Gerhardt H; Telang S; Cascante M; Chesney J; Dewerchin M; Carmeliet P
    Cell Metab; 2014 Jan; 19(1):37-48. PubMed ID: 24332967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelial PFKFB3 plays a critical role in angiogenesis.
    Xu Y; An X; Guo X; Habtetsion TG; Wang Y; Xu X; Kandala S; Li Q; Li H; Zhang C; Caldwell RB; Fulton DJ; Su Y; Hoda MN; Zhou G; Wu C; Huo Y
    Arterioscler Thromb Vasc Biol; 2014 Jun; 34(6):1231-9. PubMed ID: 24700124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase and tumor cell glycolysis.
    Chesney J
    Curr Opin Clin Nutr Metab Care; 2006 Sep; 9(5):535-9. PubMed ID: 16912547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of the Glycolytic Activator PFKFB3 in Endothelium Induces Tumor Vessel Normalization, Impairs Metastasis, and Improves Chemotherapy.
    Cantelmo AR; Conradi LC; Brajic A; Goveia J; Kalucka J; Pircher A; Chaturvedi P; Hol J; Thienpont B; Teuwen LA; Schoors S; Boeckx B; Vriens J; Kuchnio A; Veys K; Cruys B; Finotto L; Treps L; Stav-Noraas TE; Bifari F; Stapor P; Decimo I; Kampen K; De Bock K; Haraldsen G; Schoonjans L; Rabelink T; Eelen G; Ghesquière B; Rehman J; Lambrechts D; Malik AB; Dewerchin M; Carmeliet P
    Cancer Cell; 2016 Dec; 30(6):968-985. PubMed ID: 27866851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PFKFB3 is involved in breast cancer proliferation, migration, invasion and angiogenesis.
    Peng F; Li Q; Sun JY; Luo Y; Chen M; Bao Y
    Int J Oncol; 2018 Mar; 52(3):945-954. PubMed ID: 29393396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estradiol stimulates glucose metabolism via 6-phosphofructo-2-kinase (PFKFB3).
    Imbert-Fernandez Y; Clem BF; O'Neal J; Kerr DA; Spaulding R; Lanceta L; Clem AL; Telang S; Chesney J
    J Biol Chem; 2014 Mar; 289(13):9440-8. PubMed ID: 24515104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.